Documents & Downloads

Nefopam-d3

Centrally Acting Analgesic Drug

Nefopam-d3 is a deuterium-labeled derivative of Nefopam, a centrally acting non-opioid analgesic. This compound primarily targets β-catenin protein levels in mesenchymal cells, influencing pain pathways. Nefopam-d3 serves as a valuable tool for research into pain management and the molecular mechanisms of analgesic action. Its deuterium labeling allows for enhanced tracking and analysis in pharmacokinetic studies.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	1346747-15-6
Applications	Centrally Acting Analgesic Drug
Formula	C₁₇H₁₆D₃NO
Molecular Weight	256.36
Synonyms	Fenazoxine-d3
SMILES	[2H]C([2H])([2H])N1CCOC(C2=CC=CC=C2)C3=CC=CC=C3C1

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.